Titre : | Cannabidiol use in France in 2022: Results from a nationwide representative sample of adults (2024) |
Auteurs : | T. BARRÉ ; E. LAHAIE ; V. DI BEO ; P. CARRIERI ; R. ANDLER ; V. NGUYEN THANH ; F. BECK |
Type de document : | Article : Périodique |
Dans : | Drug and Alcohol Review (Online first 01/04/2024, 2024) |
Article en page(s) : | doi: 10.1111/dar.13842 |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus géographique FRANCEThésaurus mots-clés CANNABIDIOL ; ADULTE ; PREVALENCE ; VOIE D'ADMINISTRATION ; FUMER ; TABAC ; INHALATION ; AGE ; CANNABINOIDESOrganismes SANTE PUBLIQUE FRANCE |
Résumé : |
INTRODUCTION: Cannabidiol (CBD) is a non-intoxicating cannabis compound found in diverse commercial products worldwide. However, its use may not be fully harmless. Accordingly, it is important to document the prevalence of CBD use and user characteristics in the general population.
METHODS: We conducted a nationwide survey from a random sample of adults living in France using computer-assisted telephone interviews between 2 March and 9 July 2022. We estimated the prevalence of CBD awareness and CBD use, and explored the different routes of administration. We also performed logistic regression models to identify factors associated with past-year CBD use. RESULTS: Based on data from 3229 participants, we estimated that 71.0% (95% confidence interval) (69.0-73.0) of the French adult population had heard of CBD, and 10.1% (8.7-11.4) had used it in the previous year. Past-year CBD use was associated with younger age, a higher educational level, not living in a middle-sized urban unit, tobacco consumption and e-cigarette use. The most common route of administration was smoking (56.1%). DISCUSSION AND CONCLUSION: Past-year CBD use prevalence in France appeared to be as high as that for cannabis. Proper prevention, regulation and control of CBD products is necessary to ensure that people have access to safe and high-quality products. Reliable information on CBD should be sought and disseminated, especially regarding the harms associated with smoking the compound. Key Points: Cannabidiol is easily accessible in France and Europe. Cannabidiol use may come with certain risks. Ten percent of French adults used cannabidiol in the previous year. The most common route of cannabidiol administration was smoking. |
Domaine : | Autres substances / Other substances ; Tabac / Tobacco / e-cigarette |
Refs biblio. : | 51 |
Affiliation : |
Aix-Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France Santé Publique France, Saint-Maurice, France Centre de Recherche en Épidémiologie et Santé des Populations, Inserm U1018, Université Paris-Saclay, Université Paris-Sud, Université Versailles Saint-Quentin, Villejuif, France |
Lien : | https://doi.org/10.1111/dar.13842 |
Accueil